Form 4: Hims & Hers CFO Oluyemi Okupe Reports Routine Stock Transactions Including RSU Vesting and Tax-Related Share Sale

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, reported the vesting of Restricted Stock Units (RSUs) and a subsequent sale of shares to cover tax obligations, alongside an increase in direct and indirect beneficial ownership.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported transactions on June 13, 2025.
• The transactions included the acquisition of 105,199 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Concurrently, 58,023 shares of Class A Common Stock were disposed of at a price of $55.48 per share, primarily to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Mr. Okupe directly beneficially owns 86,329 shares of Class A Common Stock.
• Additionally, 70,575 shares are indirectly beneficially owned through the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
• Multiple tranches of Restricted Stock Units (RSUs) vested, converting into Class A Common Stock, with varying service-based vesting schedules over a 4-year period, typically in quarterly installments.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions related to executive compensation (RSU vesting and tax-related share sale). It does not contain information that would significantly alter the company's perceived financial health or strategic direction, thus indicating a neutral sentiment.

Positives

• The vesting of Restricted Stock Units (RSUs) indicates the fulfillment of service-based compensation requirements for the Chief Financial Officer.
• The acquisition of 105,199 shares through RSU vesting demonstrates continued equity alignment between the executive and shareholders.
• The executive maintains significant direct and indirect beneficial ownership in the company following the transactions.

Negatives

• A disposition of 58,023 shares occurred, reducing the executive's direct share count, although this was primarily for tax withholding purposes.

Future Outlook

The document details future RSU vesting schedules, indicating ongoing service-based compensation for the Chief Financial Officer, with quarterly vesting dates on March 15, June 15, September 15, and December 15.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, specifically related to executive compensation through Restricted Stock Units. Such filings are common across all industries for publicly traded companies and do not provide specific industry-wide insights.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a standard practice across many industries, aligning executive incentives with long-term shareholder value.
• The disposition of shares to cover tax obligations upon RSU vesting is a common and expected event for executives receiving equity compensation, consistent with industry norms for managing tax liabilities.

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation and do not indicate a significant change in company strategy or financial performance. The sale for tax purposes is a common occurrence and does not necessarily reflect a lack of confidence.
• Employees: The RSU vesting demonstrates the company's standard equity compensation practices for its executives.

Next Steps

• Continued vesting of remaining Restricted Stock Units (RSUs) on specified Company Quarterly Vesting Dates (March 15, June 15, September 15, December 15) over the respective 4-year periods.

Key Dates

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Chief Financial Officer, Equity Compensation, Stock Sale, Tax Withholding